Literature DB >> 15689961

Neural response to emotional salience in schizophrenia.

Stephan F Taylor1, K Luan Phan, Jennifer C Britton, Israel Liberzon.   

Abstract

Neuroimaging probes of brain regions implicated in emotion represent an important research strategy for understanding emotional dysfunction in schizophrenia. Anterior limbic structures, such as the ventral striatum and the amygdala, have been implicated in the pathophysiology of schizophrenia and the generation of emotional responses, although few studies to date have used emotion probes to target these areas in schizophrenia. With this goal in mind, emotionally salient visual images were used in a simple, nondemanding task. In all, 13 medicated, schizophrenic patients, five unmedicated patients, and 10 healthy volunteers viewed complex visual pictures and a nonsalient, blank screen while regional cerebral blood flow was measured with the [O-15] water technique. Pictures consisted of real world scenes with aversive, positive, and nonaversive content. Eye movements were recorded simultaneous with scan acquisition. Positron emission tomography images were analyzed for baseline, tonic activity, in addition to phasic changes ('activation') to salient stimuli. Lateral eye movement measures and on-line ratings showed good behavioral compliance with the task. Patients with schizophrenia showed impaired neural responses to salient stimuli in the right ventral striatum (VS), and they exhibited elevated tonic activity levels in the right VS and bilateral amygdala, inversely correlated with overall symptom severity. The patients also showed reduced modulation of visual cortex by salient stimuli. The results show that patients with schizophrenia exhibit impaired neural responses to emotionally salient stimuli in the VS, supporting a role for this structure in the pathophysiology of the illness. Reduced modulation of visual cortex by emotionally salient stimuli also suggests a failure to organize cerebral activity at a global level.

Entities:  

Mesh:

Year:  2005        PMID: 15689961     DOI: 10.1038/sj.npp.1300679

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  62 in total

1.  Brain mapping biomarkers of socio-emotional processing in schizophrenia.

Authors:  Stephan F Taylor; Angus W MacDonald
Journal:  Schizophr Bull       Date:  2011-09-30       Impact factor: 9.306

Review 2.  All that glitters ... dissociating attention and outcome expectancy from prediction errors signals.

Authors:  Matthew R Roesch; Donna J Calu; Guillem R Esber; Geoffrey Schoenbaum
Journal:  J Neurophysiol       Date:  2010-06-16       Impact factor: 2.714

Review 3.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

4.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

5.  Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.

Authors:  Jocelyn M Richard; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

6.  Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia.

Authors:  James A Waltz; Julie B Schweitzer; Thomas J Ross; Pradeep K Kurup; Betty J Salmeron; Emma J Rose; James M Gold; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

Review 7.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

8.  Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators.

Authors:  Erin C Dowd; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

9.  Attenuated modulation of the N170 ERP by facial expressions in schizophrenia.

Authors:  S K Lynn; D F Salisbury
Journal:  Clin EEG Neurosci       Date:  2008-04       Impact factor: 1.843

10.  Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.

Authors:  Xiaochuan Guo; Peter J Hamilton; Nicholas J Reish; J David Sweatt; Courtney A Miller; Gavin Rumbaugh
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.